Stockwinners Market Radar for September 18, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:32 EDT Deutsche Bank lowers prime lending rate to 5.00% from 5.25% - Deutsche Bank announced that its New York Branch, Deutsche Bank New York, and its subsidiary Deutsche Bank Trust Company Americas have decreased their prime lending from 5.25% to 5.00% effective tomorrow, September 19, 2019.

18:46 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Herman Miller (MLHR) up 9.1%. ALSO HIGHER: Savara (SVRA) up 11.1% after announcing presentation of additional data for Molgradex at ERS... China Biologic (CBPO) up 7.6% after disclosing "going private" offer from Beachhead Holdings and Citic Capital... NCR Corp (NCR) up 3.4% after backing FY19 guidance, retiring convertible preferred stock... Microsoft (MSFT) up 1.3% after announcing new $40B buyback, raising dividend by 11%... Tandem Diabetes (TNDM) up 1.3% after disclosing t:slim X2 pump results. DOWN AFTER EARNINGS: U.S. Steel (X) down 8.7% after negative Q3 pre-announcement. ALSO LOWER: Provention Bio (PRVB) down 9.4% after equity offering... Plains All American (PAA) down 1.7% after secondary offerings... Costco (COST) down 0.8% after being cut to Underperform at Bernstein. Movers as of 18:30ET.

18:30 EDT Agco CEO: We are on schedule in the U.S. - In an interview on CNBC's Mad Money, Agco CEO Martin Richenhagen said: We have reinvented the combine...The Fendt ideal combine replaces four conventional smaller ones... We are on schedule in the U.S. and should hit our guidance... American farmers are getting more subsidies than usual.

18:00 EDT SunTrust lowers prime lending rate to 5% from 5.25% - Following the Federal Reserve's announcement to lower the Federal Funds rate, SunTrust Bank announced it has lowered its prime lending rate to 5.00% from 5.25%, effective September 19, 2019. The prime rate is a benchmark used to set interest rates on various forms of consumer and commercial loans. The prime rate last changed on August 1, 2019.

17:52 EDT HSBC decreases prime lending rate to 5% from 5.25% - HSBC Bank USA and its affiliates announced that they have lowered their prime and reference rates to 5.00% from 5.25%, effective Septemer 19.

17:46 EDT Associated Banc-Corp lowers prime rate to 5.0% from 5.25% - Effective September 19.

17:43 EDT China Biologic up 7% after receiving 'going private' proposal for $120 per share - In after-hours trading, shares are up approximately 7% to $110.20.

17:39 EDT Hess' Lowery-Yilmaz sells 19,189 common shares - In a regulatory filing, Hess senior VP Barbara J. Lowery-Yilmaz disclosed the sale of 19,189 common shares of the company on September 16 at a price of $70.65 per share.

17:33 EDT Ezcorp board elects Phillip Cohen as Executive Chairman - EZCORP announced that Phillip Cohen has been elected to the Board of Directors and appointed as Executive Chairman, both effective September 12. In addition, the Board created the position of Lead Independent Director to serve as principal liaison between the Executive Chairman and the Chief Executive Officer and the independent directors, and elected Matthew W. Appel to serve in that role. Mr. Appel has been a member of the Board since January 2015 and also serves as Chair of the Audit Committee. The company's prior Executive Chairman, Lachlan P. Given, resigned from that position and as a member of the Board, but will continue to serve as an executive officer of the Company, principally responsible for the Company's merger and acquisition and funding activities.

17:27 EDT Booz Allen, ManTech and SAIC awarded on up to $950M Air Force contract - Booz Allen Hamilton (BAH), ManTech (MANT), SAIC (SAIC) and others have been awarded a not-to-exceed $950M multiple award, indefinite-delivery/indefinite-quantity contract for analytical and technical services. This contract vehicle provides for analytical and technical services for the Secretary of the Air Force's concepts, development and management office. Work will be performed as indicated in each order and is expected to be completed by September 2029. This award is the result of a competitive acquisition and 10 offers received. FY19 operations and maintenance funds in the amount of $5,000 are being obligated to each of the eight initial task orders. The Secretary of the Air Force's concepts, development and management office is the contracting activity.

17:24 EDT Citizens Financial decreases prime lending rate to 5% from 5.25% - Citizens Financial Group announced that Citizens Bank has lowered its prime lending rate to 5.00% from 5.25%, effective Thursday, September 19.

17:17 EDT BB&T decreases prime lending rate to 5% from 5.25% - BB&T Corporation announced it is decreasing its prime lending rate to 5.00% from 5.25% effective immediately.

17:14 EDT Contura Energy agrees to resolve Powder River Basin Mines claims - Contura Energy announced that it has entered into an agreement with Eagle Specialty Materials related to its interest in acquiring and operating the Eagle Butte and Belle Ayr thermal coal mines located in the Powder River Basin in Campbell County, Wyoming. Pursuant to the terms of the agreement announced today, Contura and Eagle Specialty Materials will use commercially reasonable efforts to enter into definitive agreements with the Debtors; third-party sureties; local, state, and federal governmental entities; and other interested parties as necessary to accomplish the purchase and subsequent immediate operation of the Western Assets by Eagle Specialty Materials, the transfer of certain state and federal permits and leases from both Contura and Blackjewel to Eagle Specialty Materials, and the replacement of Contura-held bonds related to the Western Assets with new bonding provided by Eagle Specialty Materials. Also pursuant to the agreement, subject to closing and certain other covenants and conditions, Contura will provide $90.0M in cash and convey certain Wyoming real property to Eagle Specialty Materials, will pay $13.5M to Campbell County, Wyoming for ad valorem back taxes, and will waive its rights to the remaining $3.05M of the previously-referenced purchase deposit provided to the Debtors. Concurrently, Eagle Specialty Materials will make a specified cash payment to the Debtors, will assume all reclamation obligations and certain other liabilities relating to the Western Assets, will pay off certain debts owed by the Debtors, including certain debtor-in-possession financing, and will agree to make certain payments in respect of royalties, taxes, Abandoned Mine Land reclamation fees, and other amounts arising from the permitted mining operations.

17:05 EDT Progenics confirms notice of consent solicitation by Velan to gain board seats - Progenics confirmed that Velan Capital filed with the SEC notice of its intent to solicit consents to gain control of five of the seven seats on the company's board. Since the Annual Meeting held just two months ago, Velan is attempting to remove three duly elected members of Progenics' Board of Directors and fill these board seats, as well as the seats to be vacated by Peter J. Crowley and Michael D. Kishbauch, with five of its own nominees. The company states: "The Progenics Board, in consultation with its financial and legal advisors, is carefully reviewing Velan's filing and will communicate with shareholders in due course. The Progenics Board is deeply disappointed that Velan has chosen to pursue a distracting and value-destructive consent solicitation campaign rather than working constructively with the company to reach a mutually agreeable resolution in the best interests of all shareholders. Velan asserted in a press release issued upon its SEC filing that Progenics has failed to engage with it. This is simply false. Since the Annual Meeting in July, the company has continued to engage with Velan in good faith and has made numerous and reasonable settlement proposals to avoid a costly and distracting consent solicitation."

17:02 EDT Wells Fargo decreases prime rate to 5.00% - Wells Fargo Bank said it is decreasing its prime rate to 5.00% from 5.25%, effective, Sept. 19.

16:59 EDT Stoneridge announces MirrorEye CMS award worth $10M in peak annual revenue - Stoneridge announced its second MirrorEye camera monitor system, or CMS, award with a commercial vehicle OEM. The award represents an estimated $10M in peak annual revenue based on forecasted production levels and an assumed penetration rate of the system of 10%-15%. Production is scheduled to begin in 2021. Stoneridge's MirrorEye CMS replaces traditional rear and side view mirrors with digital cameras. In addition to having OEM awards for MirrorEye, Stoneridge remains the only company in the world with an exemption from the Federal Motor Carrier Safety Administration, or FMCSA, to replace traditional mirrors with the MirrorEye CMS on commercial vehicles in the U.S.

16:51 EDT Pioneer Natural CTO sells 5,619 common shares - In a regulatory filing, Pioneer Natural EVP and chief technology officer Chris J. Cheatwood disclosed the sale of 5,619 common shares of the company at a price of $140.348 per share.

16:34 EDT II-VI launches 400 mW micro-pump laser in next-gen transceivers - II-VI announced the introduction of its 400 mW micro-pump laser for high-temperature operation. Next-generation coherent transmission applications continue to demand amplifiers that can operate efficiently in space-, power- and thermally-constrained environments. II-VI's industry-leading single-mode uncooled micro-pump laser maintains a high output power of 400 mW, with only 1 Watt of power consumption, in environments where temperatures can reach 85 degrees Celsius. The micro-pumps are available with 80 mum PM980 and 125 mum HI 1060 single-mode fibers, which can achieve a very tight bend radius to match the micro-pump's small 10 x 4.4 mm package footprint.

16:31 EDT Huntington Bancshares lowers prime lending rate to 5.0% from 5.25% - Effective September 19.

16:31 EDT U.S. Steel sees Q3 adj. EBITDA to be approximately $115M - "The positive flat-rolled steel market indicators experienced earlier this summer have softened after a brief recovery in steel selling prices. The impact of falling steel prices through the second quarter, combined with the impact of a larger than expected drop in scrap prices on market sentiment, is expected to negatively impact Flat-rolled earnings in the second half of the year. As a result, our current assessment of the Flat-rolled segment suggests two blast furnaces will remain idled through at least the end of the year. Based on the continued idling of our two U.S. blast furnaces and current demand forecasts, we now expect full year Flat-rolled shipments to third party customers to be approximately 10.7 million tons. We will continue to evaluate our footprint to best match our production with our order book. In Europe, market conditions have continued to deteriorate, as the dislocation between steel selling prices and raw material costs continues to result in significant margin compression. Based on current market conditions and the continued high level of steel imports into Europe, we do not expect to restart the currently idled blast furnace this year. As a result, we reiterate our full year shipment guidance of approximately 3.6M tons. We also continue to execute our labor productivity strategy at U. S. Steel Europe, which includes a headcount reduction of 2,500 by the end of 2021. To date, we have eliminated approximately 1,800 positions. We expect our Tubular segment to remain under pressure for the remainder of the year as market conditions have turned negative and import levels remain high. Weaker demand for oil country tubular goods product, which has reduced our full year shipment expectation to approximately 0.7 million tons, and lower selling prices for seamless and welded pipe, are expected to have a significantly negative impact on earnings in the second half of the year," said the company in a statement.

16:30 EDT China Biologic trading resumes

16:20 EDT Savara to present additional Molgradex data at ERS - Savara announced that additional data from IMPALA, an ongoing pivotal Phase 3 clinical study evaluating Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor, for the treatment of autoimmune pulmonary alveolar proteinosis will be presented at the 2019 European Respiratory Society International Congress to be held in Madrid, Spain from September 28 to October 2. "We believe that these data, which extend beyond the primary endpoint to include important secondary and exploratory endpoints, provide a more holistic view of the efficacy of Molgradex in improving outcomes for aPAP patients," said Rob Neville, Chief Executive Officer, Savara. "We are confident that the totality of data demonstrates the clinical utility of Molgradex in aPAP patients and we continue to explore the best path for approval with US and European regulatory bodies."

16:16 EDT HCP announces $1B commercial paper note program - HCP announced that it has established an unsecured commercial paper program. Under the terms of the Commercial Paper Program, HCP may issue, from time to time, unsecured short-term debt securities with varying maturities not in excess of 397 days from the date of issue. Amounts available under the Commercial Paper Program may be borrowed, repaid and re-borrowed from time to time, with the maximum aggregate face or principal amount of Notes outstanding at any one time not exceeding $1B. The Notes will be sold on terms that are customary for the United States commercial paper market and will be at least equal in right of payment with all of HCP's other unsecured and unsubordinated indebtedness. The proceeds of the Notes will be used for general corporate purposes. HCP expects to use its revolving credit facility as a liquidity backstop for the repayment of the Notes issued under the Commercial Paper Program.

16:12 EDT South Plains Financial Chief Credit Officer Kevin Bass resigns - South Plains Financial, the parent company of City Bank, announced the resignation of Kevin Bass, Chief Credit Officer, effective September 16. Bass is leaving the company to pursue a career within the energy sector as CEO of a Texas-based business. A search has commenced for Bass' successor at City Bank. Bob Kotarski, current market president for City Bank in El Paso, will serve as interim Chief Credit Officer of City Bank effective immediately.

16:11 EDT Herman Miller CFO: We continue to navigate the global tariff picture effectively - Jeff Stutz, CFO, noted, "We continue to navigate the global tariff picture effectively, taking action where we can in areas around pricing and supply chain, leveraging our profit improvement initiatives and realizing benefits from lower commodity costs. Despite the gross margin pressures we are feeling in our Retail business, some of which are transitory and driven by our nearly complete transition to a new 620,000-foot distribution facility, we delivered 70 basis points of gross margin expansion at the consolidated level over the same quarter last year. Our operating performance contributed to a significant increase in earnings per share compared to last year, exceeding the expectations that we established at the start of the quarter."

16:08 EDT Microsoft announces new $40B share repurchase program, 11% dividend hike - Microsoft announced that its board of directors declared a quarterly dividend of 51c per share, reflecting a 5c or 11% increase over the previous quarter's dividend. The dividend is payable Dec. 12, to shareholders of record on Nov. 21. The ex-dividend date will be Nov. 20. The board of directors also approved a new share repurchase program authorizing up to $40B in share repurchases. The new share repurchase program, which has no expiration date, may be terminated at any time.

16:06 EDT Orion Group announces contract awards totaling about $29M - Orion Group Holdings announced contract awards totaling approximately $29M. The Company's Concrete segment has been awarded two separate contracts for light commercial projects in its Houston, Texas market totaling approximately $22M. The company's work on these projects is expected to begin in the third quarter with a duration of approximately eight months. In addition, the company's Concrete segment has been awarded a contract for approximately $7M for a structural project in the Dallas/Fort Worth area. This project is expected to begin in the third quarter with a duration of approximately 11 months.

16:04 EDT China Biologic receives preliminary "going private" proposal for $120 per share - China Biologic has received a preliminary non-binding proposal letter from Beachhead Holdings, CITIC Capital China Partners IV, PW Medtech Group, Parfield International, HH Sum-XXII Holdings and V-Sciences Investments proposing to acquire all of the outstanding ordinary shares of the company not already owned by the Buyer Group for $120 per share in cash in a "going private" transaction. No decisions have been made with respect to the company's response to the transaction.

15:58 EDT PNC Financial lowers prime rate to 5% - PNC announced a decrease in its prime lending rate. The new rate of 5% is effective tomorrow, Sept. 19.

15:29 EDT China's CATL to supply batteries for Daimler electric trucks - Daimler Trucks & Buses and battery manufacturer Contemporary Amperex Technology,CATL,have entered a global battery cell modules supply agreement for electric series trucks. CATL will supply lithium-ion battery cell modules for a wide range of Daimler Trucks & Buses' global electric truck portfolio to be introduced in markets from 2021 onwards, including the Mercedes-Benz eActros, the Freightliner eCascadia and the Freightliner eM2. The development of the battery systems lies with Daimler Trucks & Buses. Battery pack assembly will be carried out by Daimler Trucks & Buses as well -- at its Mercedes-Benz Mannheim plant in Germany and its Detroit plant in the US.

15:19 EDT M&T Bank lowers prime lending rate to 5.0% from 5.25% - Effective Thursday, September 19, M&T Bank will decrease its prime lending rate from 5.25% to 5.00%.

15:01 EDT Friedman Industries names Michael J. Taylor president, CEO - Friedman Industries announced the appointment of Michael J. Taylor as President and Chief Executive Officer of the company, effective September 12, 2019. Taylor has served as the Interim President and Interim Chief Executive Officer since February 12, 2019 and has served as a director of the company since December 2016 and as chairman of the board of directors since June 2017. Taylor will continue to serve as a director of the company and chairman of the board. Prior to joining the company in December 2016 and his prior retirement, Taylor served as President of Cargill Metals Supply Chain, a large steel processing and distribution company, from 2003 to 2014.

14:42 EDT Fifth Third decreases prime lending rate to 5% - Fifth Third Bank announced it will decrease its prime lending rate to 5% from 5.25%, effective immediately.

14:22 EDT Pennsylvania joining multistate lawsuit to block T-Mobile, Sprint merger - New York Attorney General Letitia James announced that the Commonwealth of Pennsylvania is joining the multistate lawsuit to block the merger of telecommunications giants T-Mobile (TMUS) and Sprint (S), becoming the 18th plaintiff to join the lawsuit. In a statement Attorney General James said that, "Pennsylvania's addition to our lawsuit adds to the states' momentum against this megamerger that continues to be bad for consumers, bad for workers, and bad for innovation. We welcome Pennsylvania and Attorney General Shapiro to our multistate coalition that continues to build strength, and now includes every region of the nation." "The merger between T-Mobile and Sprint would severely undermine competition in the telecommunications sector, which would hurt Pennsylvanian consumers by driving up prices, limiting coverage, and diminishing quality. I'm proud to stand with my colleague Attorneys General in opposing this merger and advocating on behalf of Pennsylvania consumers," Pennsylvania Attorney General Josh Shapiro added. Attorney General Shapiro will become the 18th attorney general to challenge the merger of T-Mobile and Sprint, adding to the forward progress initiated by Attorney General James and the Attorneys General of California, Colorado, Connecticut, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nevada, Oregon, Texas, Virginia, Wisconsin, and the District of Columbia.

14:17 EDT Cryoport CEO expects no contract interruption with Novartis, Gilead - Cryoport (CYRX) provides cold chain logistics solutions for temperature-sensitive life sciences materials. In an exclusive interview with The Fly, the company's President and CEO Jerry Shelton talked about a recent cautious report on Cryoport by a Seeking Alpha contributor, Mako Research. The article cited the contracts with Gilead (GILD) and Novartis (NVS) that it claimed were set to expire in 2020: "The problem with technology is that bad reports can get out and inaccuracies can get out into the marketplace and Seeking Alpha is such an event. It was a very poorly written article with very little truth to it. The contracts that we have with these two companies - Gilead and Novartis - are evergreen contracts. We set the usual term of all contracts that we negotiate to three years because it's a very fast changing, very fast-moving industry. Once we have reached that foundational point, the contracts turn evergreen. So, they're automatically renewed every year. We are entrenched in both of these companies. We provided all of the support - from clinical trials all the way through commercial activity to date - and we see no anticipation whatsoever in interruption of service or our arrangements with either company." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.

14:12 EDT McDermott down 55% to $2.66 as shares continue to be volatile - McDermott International said earlier that it "routinely hires external advisors to evaluate opportunities for the company." The company did not confirm in its statement that it has hired turnaround consulting firm AlixPartners, as reported by The Wall Street Journal and Bloomberg.

13:58 EDT McDermott off lows after resuming, still down 44% - Shares of McDermott (MDR) were down $2.60, or 44%, to $3.28 after resuming trading. However, the stock was then quickly halted again for volatility.

13:40 EDT Cryoport focused on providing 'reliable' solutions for life sciences, CEO says - Cryoport (CYRX) provides cold chain logistics solutions for temperature-sensitive life sciences materials. In an exclusive interview with The Fly, the company's President and CEO Jerry Shelton talked about Cryoport's business and its mission: "Cryoport is the world's premier provider of temperature control solutions for the life sciences industry. We serve the biopharma reproductive medicine and the animal health markets on a global basis, and our mission is to support life and health on Earth by providing reliable and comprehensive solutions for life sciences with our advanced technology, global supply chain network, and dedicated scientists technicians and supporting team of professionals. Throughout purpose-built packaging information technology, smart sustainable cold chain logistics and bio storage biobanking services, Cryoport helps its customers advance life sciences research and develop vaccines, medicines, IVF treatments and life-saving advanced therapies in over a hundred countries around the world. Those services include logistic support, bio Services - which includes storage, packaging and labeling, and fulfillment for allergen therapies." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.

13:40 EDT McDermott says 'routinely hires external advisers' to evaluate opportunities - McDermott International said in a statement that it "routinely hires external advisors to evaluate opportunities for the company. The company is taking positive and proactive measures, as we have done in the past, intended to improve its capital structure and the long-term health of its balance sheet."

13:07 EDT Cryoport CEO says Seeking Alpha contributor report has 'very little truth to it'

13:04 EDT Cryoport, Vineti collaboration provides broad-based global solution, CEO says

13:04 EDT Cryport CEO says Seeking Alpha contributor report has 'very little truth to it'

12:47 EDT Gundlach sees 'increasing probability' of recession before 2020 election - Jeffrey Gundlach of DoubleLine Capital is speaking on CNBC.

12:44 EDT Great Southern Bancorp raises quarterly dividend 6% to 34c per share - The Board of Directors of Great Southern Bancorp declared a 34c per common share dividend for the third quarter of the calendar year ending December 31, 2019. This dividend represents a 6% increase from the previous quarter's dividend of 32c per common share. The dividend will be payable on October 14, 2019, to shareholders of record on September 30, 2019. This dividend represents the 119th consecutive quarterly dividend paid by the Company to common shareholders.

12:40 EDT Gundlach says markets 'in fairly stable place right now' - Jeffrey Gundlach of DoubleLine Capital is speaking on CNBC.

12:36 EDT Gundlach says 'everybody knows' Fed cutting 1/4 point today - Jeffrey Gundlach of DoubleLine Capital is speaking on CNBC.

12:09 EDT Avaya, IBM sign agreement to accelerate hybrid cloud strategy - Avaya Holdings (AVYA) and IBM (IBM) announced that Avaya will adopt hybrid cloud solutions from IBM to help expand its Avaya ReadyNow private cloud unified communications and contact center offerings internationally and accelerate modernization. Avaya is expanding the availability of its Avaya ReadyNow private cloud offerings in order to help meet growing demand from clients across the globe. By working with IBM to implement a hybrid cloud strategy, Avaya said it "plans to tap into advanced technologies like AI to modernize its offering while enabling its customers to benefit from the scale and performance of IBM's global footprint of cloud data centers. By hosting and managing select services on a private cloud, Avaya aims to deliver secure and resilient solutions to its clients and service their needs more efficiently while accessing higher value services that can help transform their customer experience."

12:04 EDT Siemens names Michael Sen co-CEO of Gas and Power Operating Company - Siemens announced that managing board member Michael Sen - whose current duties include responsibility for the company's equity investment in Siemens Gamesa Renewable Energy - will be proposed at the comapny's regular meeting today as CEO of the new company in the energy and electricity sector. Plans call for publicly listing the business in September 2020. Michael Sen has also been appointed Co-CEO with Lisa Davis of Siemens' Gas and Power Operating Company, effective October 1, 2019. Lisa Davis previously informed the Supervisory Board that, for personal reasons, she did not wish to further extend her present contract. Until the ordinary Annual Shareholders' Meeting in 2020, she will ensure an orderly handover of her leadership responsibilities to Michael Sen. Lisa Davis will subsequently support the President and CEO of Siemens AG in an advisory capacity until her contract expires. The Supervisory Board also appointed Managing Board member Roland Busch Deputy Chief Executive Officer, effective October 1, 2019, and Labor Director of Siemens AG, effective December 1, 2019. Roland Busch will also be responsible for the implementation of the Vision 2020+ strategy. Janina Kugel, Chief Human Resources Officer and Labor Director of Siemens AG, will support the change process until her contract expires at the end of January 2020. In the summer of 2020, the Supervisory Board will make the decision regarding the successor and timing of succession to Joe Kaeser as President and CEO of Siemens AG.

12:02 EDT Air Liquide to invest over $270M in two air separation units, assets - Air Liquide (AIQUY) announced an agreement with Methanex Corporation (MEOH) to supply oxygen, nitrogen and utilities to its upcoming methanol plant expansion project in Geismar, Louisiana. To serve Methanex and its other customers in the industrial basin that encompasses Geismar and Baton Rouge, Air Liquide will invest more than $270M in two new large Air Separation Units and infrastructure assets connected to its Mississippi River Pipeline, and significantly increase its production capacity in the U.S. Gulf Coast region. To support the levels of oxygen and nitrogen needed at Methanex's third methanol plant in Geismar, as well as other customers along its Mississippi River Pipeline System, Air Liquide will build two new Air Separation Units with a capacity of 2,500 tons/day of oxygen each - increasing the company's Mississippi River Pipeline's supply capacity by more than 25%. Air Liquide's agreement with Methanex further strengthens Air Liquide's position in the U.S. Gulf Coast region, and the dynamic industrial basin between Geismar and Baton Rouge. The new Air Separation Units are expected to start production in mid 2022 to support Methanex's production of methanol. This investment also enhances the competitiveness of Air Liquide in one of the major industrial basins by modernizing its asset fleet and increasing energy efficiency, further reducing the carbon intensity of its operations and contributing to achieving the Group's 2025 Climate Objectives.

11:47 EDT Lianluo Smart Limited receives Nasdaq letter on bid price deficiency - Lianluo Smart Limited announced that on September 11, 2019, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company's common stock on Nasdaq. Under the Nasdaq Listing Rules, the Company has until March 9, 2020 to regain compliance. If at any time during such 180-day period the closing bid price of the Company's common shares is at least $1 for a minimum of 10 consecutive business days, Nasdaq will provide the Company written confirmation of compliance.

11:31 EDT Trump says he is revoking California's Federal Waiver on emissions - U.S. President Donald Trump said via Twitter that his administration is revoking California's Federal Waiver on emissions "in order to produce far less expensive cars for the consumer, while at the same time making the cars substantially SAFER." The president claimed in several tweets that the move would lead to more production because of a pricing and safety advantage as well as "the fact that older, highly polluting cars, will be replaced by new, extremely environmentally friendly cars. "There will be very little difference in emissions between the California Standard and the new U.S. Standard, but the cars will be far safer and much less expensive," Trump tweeted. "Many more cars will be produced under the new and uniform standard, meaning significantly more JOBS, JOBS, JOBS! Automakers should seize this opportunity because without this alternative to California, you will be out of business." Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Tesla (TSLA), Toyota (TM) and Volkswagen (VWAGY). Reference Link

11:12 EDT Comcast to include Xfinity Flex streaming box free for internet-only customers - Comcast (CMCSA) announced earlier that Xfinity Flex is now included with an Xfinity Internet-only subscription, "providing millions of new and existing customers with the ability to easily access their favorite streaming services and manage their connected home devices right on the TV." An Xfinity Flex box is included, along with the Xfinity Voice Remote, at no additional cost as part of an Xfinity Internet-only subscription, the company said. Additional boxes will be available to lease for $5 per month per box, with a limit of two boxes per customer, Comcast announced earlier. Following Comcast's announcement, shares of Roku (ROKU), which sells streaming hardware and offers streaming services, are down 10% in morning trading.

11:03 EDT Sprint, Duke Energy announce 12-year virtual power purchase agreement - Sprint (S) and Duke Energy Renewables, a commercial business unit of Duke Energy (DUK), announced a 12-year virtual power purchase agreement for 173.3 megawatts of new wind energy. Duke Energy Renewables will build, own and operate the 182-MW Maryneal Windpower project located in Nolan County, Texas, that will come online in 2020. The agreement will enable Sprint to significantly reduce its carbon footprint and achieve approximately 30% renewable energy for its total electricity portfolio. The project will provide enough renewable energy to power the equivalent of more than 54,000 U.S. homes and will reduce carbon emissions equivalent to removing more than 96,000 cars from the road annually. The Maryneal project increases Duke Energy Renewables' U.S. wind capacity to more than 3,000 MW. Full notice to proceed with construction will begin in early 2020 and the wind project will be fully operational by December 2020. During peak construction, the project will create approximately 200 jobs. Nordex Acciona will supply 38 4.8-MW wind turbines for the site. Wanzek Construction is the contractor for the project.

10:56 EDT McDermott trading resumes

10:48 EDT BAE Systems receives $170.7M in contracts from U.S. Navy for maintenance - BAE Systems has received $170.7M in contracts from the U.S. Navy to perform simultaneous maintenance and repair on two Arleigh Burke-class guided-missile destroyers in its San Diego shipyard. Under the awarded contracts, the shipyard will tandem dry-dock the USS Stethem and USS Decatur in October. The synchronized two-ship docking will be a first for the company's newest dry-dock in San Diego. The contracts include options that, if exercised, would bring the cumulative value to $185M.

10:04 EDT Loop Energy announces cash investment from Cummins - Loop Energy announced that the company has received a cash investment from Cummins. Loop Energy will also supply Cummins with range extender systems for incorporation into demonstration trucks. Loop's no-compromise module provides a breakthrough in terms of cost and power density, allowing truck operators to transition to zero-emissions without an impact to cost of ownership.

10:00 EDT NeoPhotonics falls -11.3% - NeoPhotonics is down -11.3%, or -78c to $6.13.

10:00 EDT NL Industries rises 4.9% - NL Industries is up 4.9%, or 18c to $3.91.

10:00 EDT Gain Capital rises 6.2% - Gain Capital is up 6.2%, or 34c to $5.85.

09:47 EDT NeoPhotonics falls -6.1% - NeoPhotonics is down -6.1%, or -42c to $6.49.

09:47 EDT Bright Scholar rises 3.9% - Bright Scholar is up 3.9%, or 36c to $9.66.

09:47 EDT Britannia Bulk rises 4.6% - Britannia Bulk is up 4.6%, or 20c to $4.59.

09:25 EDT SuperCom subsidiary LCA wins new project in California for up to $212K annually - SuperCom subsidiary Leaders in Community Alternatives or LCA has won a new project contract with a Central Coast California county to provide Adult Intervention and Treatment services, valued at up to $212K per year. The contract focuses on services to Adults with a focus on workforce services and employment readiness to reduce recidivism. This is a new contract for a period of one year and renewable for additional years based upon funding. The contract commenced in the summer of 2019 and the project has launched already.

09:05 EDT Apollo Endosurgery gets FDA clearance for polypropylene suture-anchor assembly - Apollo Endosurgery announced that it has received 510 clearance from the FDA for its polypropylene suture-anchor assembly for use specifically with the OverStitch endoscopic suturing systems. This proprietary suture-anchor implant is used as part of Apollo's OverStitch and OverStitch Sx endoscopic suturing systems to pass and anchor suture in the gastrointestinal tract.

09:03 EDT MKS Instruments appoints James Schreiner as SVP, COO - MKS Instruments (MKSI) announced that James Schreiner joined MKS on September 16, 2019 as SVP and COO. Schreiner succeeds Dr. John T.C. Lee as COO and will report to Dr. Lee, who is President of MKS and, as previously announced, will become CEO effective January 1, 2020. Schreiner joins MKS from Emerson Electric (EMR), where he was most recently the SVP of Global Operations for the Measurement & Analytical Group of Automation Solutions.

09:03 EDT Arthur J. Gallagher acquires Allied Insurance Brokers - Arthur J. Gallagher acquired Pittsburgh, Pa.-based Allied Insurance Brokers and its subsidiary, Ascinsure Specialty Risk. Terms of the transaction were not disclosed. Founded in 1982, Allied Insurance Brokers specializes in offering insurance and risk management services to crane, scaffold and equipment dealers throughout the United States, and nonprofit social services organizations in Western Pennsylvania.

08:54 EDT General Mills: Below expectation segments to improve 'significantly' in Q2

08:50 EDT General Mills expects foreign currency to be 'immaterial' to FY adjusted EPS

08:46 EDT Orbit International announces follow-on purchase order in excess of $2M - Orbit International announced that its Power Group, through its Behlman Electronics subsidiary, has been awarded a follow-on purchase order in excess of $2,000,000 for the production and delivery of 11 Common Aircraft Armament Test Sets for the U.S. Navy. Deliveries under this purchase order are expected in the fourth quarter of 2020. This follow-on award is the fourth and final production order received under a $21,709,300 fixed price indefinite delivery/indefinite quantity contract received by the Company in September 2017.

08:39 EDT General Mills: Retail sales trends for Nature Valley improved each month in Q1

08:36 EDT General Mills sees FY20 organic net sales growth 1%-2%

08:34 EDT Iron Mountain and Hyland partner in document retention application - Iron Mountain and Hyland, a content services provider for organizations around the globe, announced new capabilities to improve retention policy management for records and information stored in Hyland's OnBase enterprise information platform. The new solution, Governance Rules as a Service, integrates Policy Center's cloud-based policy management platform with OnBase to match record classes with document types and populate appropriate retention rules in OnBase with a single click.

08:33 EDT General Mills sees top line improvement for segments, company starting in Q2 - Comments taken from the Q1 earnings conference call.

08:32 EDT Realogy, HomeAdvisor partner on home improvement program - Realogy (RLGY) and HomeAdvisor announced the launch of RealVitalize, a home improvement program. This program provides home sellers with home improvement resources prior to or during the home listing period with no up-front costs or interest charges. The pilot program is currently available in select markets through the Coldwell Banker branded operations of NRT, the subsidiary that manages Realogy's company owned brokerages. The pilot program launched in the Columbus, Ohio, Denver, Colo., Orlando, Fla. and Tampa, Fla. market areas with a national roll-out planned later this year. Realogy and HomeAdvisor will continue to explore opportunities for expansion in 2020. HomeAdvisor is an operating business of ANGI Homeservices (ANGI).

08:29 EDT IsoRay announces publication of data of Cesium-131 - IsoRay reported a study of the ten-year findings on the impact of Cesium-131 internal radiation therapy in treating a series of cancer patients. The peer reviewed publication, Long-term Biochemical Outcomes Using Cesium-131 in Prostate Brachytherapy, was recently made available on the website of BRACHYTHERAPY, an international multidisciplinary journal. The publication reported on a study of a series of 571 patients who were treated with Cesium-131 prostate brachytherapy at the Chicago Prostate Cancer Center by radiation oncologist Dr. Brian J. Moran. The overall group was composed of 55% low risk, 36% intermediate risk, and 9% high risk localized prostate cancer patients as defined by NCCN ) guidelines. The majority of patients were treated with a Cesium-131 implant only, while the remainder were treated with external beam or hormone therapy -- or both - added to the Cesium-131 implant in cases of higher risk disease. Long-term results were reported for this patient group at 5, 7, and 10 years, The overall biochemical success rate for the entire group of patients at ten years was 96.2%.

08:23 EDT Agraflora Organics' Canutra awarded cannabis research license by Health Canada - AgraFlora Organics announced the Company's wholly owned subsidiary, Canutra Naturals, has been awarded a cannabis research licence by Health Canada under the Cannabis Regulations Act. The Research License permits Canutra to pursue the development of proprietary cannabis genetics and phenotypes at its flagship 76-acre campus in Kent County, New Brunswick. In conjunction with the Canutra's existing cannabis research and development partnership with the Universite de Moncton, the company will leverage its recently awarded Research License to augment its portfolio of unique cannabis genetics and phenotypes. Canutra intends to utilize its proprietary cannabis genetics and phenotypes as base-inputs for its suite of premium, cannabinoid-infused cosmetics, which are presently marketed across North America, the People's Republic of China and the Hong Kong Special Administrative Region.

08:20 EDT Overstock.com to distribute freely tradable Series A-1 shares in dividend - Overstock.com announced on July 30, 2019 that its Board of Directors had declared a dividend payable in shares of its Digital Voting Series A-1 Preferred Stock. "We have received a great deal of interest surrounding our Series A-1 dividend from shareholders, broker-dealers, regulators, and the general market. It is innovative and ground-breaking in its design - one that is structured to comply strictly with existing regulatory standards and investor protections. It also introduces blockchain technology to enhance the investor experience. It is an important step on the journey to demonstrate that blockchain technology has enormous potential to transform society for the better," said interim CEO Jonathan Johnson. "In view of the feedback we received from industry participants, investors, and regulators with respect to the Series A-1 stock dividend, and in order to provide greater liquidity, we are working with the appropriate regulatory authorities to structure the issuance of the dividend shares so they would be freely tradable by non-affiliates immediately upon distribution. We believe this will be a major benefit to investors. Thus, we will seek to register the shares with the appropriate regulatory authorities. We expect the result will be that, immediately upon distribution, such dividend shares will be freely tradable without the six-month holding period requirement under Rule 144. We are already working closely with regulators to register the shares and achieve that result. In light of this, we are postponing the previously-announced September 23, 2019 record date. We expect to announce a new record date for the dividend shares in as soon as approximately three to six weeks, as we work to conclude the registration process. Once we announce the new record date, we will also announce a new distribution date, which may be sooner or later than the previously announced November 15, 2019 distribution date."

08:18 EDT CareDx announces enrollment of first patient in OKRA registry - CareDx announced the enrollment of the first patient in the Outcomes of KidneyCare in Renal Allografts registry from the University of Maryland School of Medicine. OKRA is a multicenter, prospective, observational registry, designed to measure outcomes of kidney transplant recipients managed with KidneyCare. KidneyCare complements AlloSure to include multimodality testing with the addition of AlloMap Kidney Gene Expression Profiling and prognostic graft assessment using iBox.

08:15 EDT NV5 Global announces $10M in contracts for services in California, the Northeast - NV5 Global announced that it has been awarded $10M in contracts to provide energy consulting, program management and construction quality assurance services for prestigious infrastructure and energy projects in California, New Jersey and Pennsylvania. $6M in fees were won as a result of NV5's ENERGY 2021 initiative, which has sought to introduce new energy service offerings to NV5's existing client base. One project includes the design of a boil-off compressor for Elizabethtown Gas in New Jersey, which will convert natural gas to Liquid Natural Gas and allow for the safer and more efficient storage and shipment of natural gas products. NV5 will provide feasibility studies for a substation owned by a prominent California utility and perform land surveying for real estate and infrastructure assets throughout the utility's service area. NV5 was also awarded $4M in program management and construction quality assurance contracts. The Pennsylvania Department of General Services selected NV5 to provide program management services for the rehabilitation and modernization of the Harrisburg Military Post, a National Guard armory complex located in Dauphin County. In California, NV5 was selected by a municipality in San Joaquin County to provide program management services for infrastructure projects throughout the community. NV5 was selected by the Irvine Ranch Water District to perform construction materials testing and inspection services.

08:10 EDT Apellis announces publication of efficacy, safety data of intravitreal APL-2 - Apellis Pharmaceuticals announced details about its Phase 2 FILLY study investigating intravitreal APL-2 for the treatment of geographic atrophy secondary to age-related macular degeneration have been published in Ophthalmology, the journal of the American Academy of Ophthalmology. Publication of the full study report follows the release of topline study results earlier this year and shows that treatment with APL-2 resulted in statistically significant reductions in the growth of GA lesion area compared to sham at month 12. The FILLY study was a Phase 2, multicenter, randomized, single-masked, sham-controlled clinical trial evaluating APL-2 in 246 patients with GA secondary to AMD conducted at over 40 clinical sites in the United States, Australia and New Zealand. APL-2 was administered as an intravitreal injection monthly or every other month for 12 months, followed by six months of monitoring after the end of treatment. The primary efficacy endpoint was the change in GA lesion area from baseline to month 12 compared to sham. At 12 months, patients treated with APL-2 showed a 29% reduction in the growth of GA lesion area in the monthly treatment group and a 20% reduction in the EOM treatment group compared to the pooled sham group. Statistical significance was defined as pless than0.1 for this study. Post-hoc analysis showed that the effect was more pronounced in the last six months of treatment, with observed reductions of 45% and 33% for APL-2 monthly and EOM, respectively, compared to sham. The administration of APL-2 was generally well tolerated. There was an increased incidence of exudation in APL-2 treated eyes compared to sham-treated eyes, which was manageable with the administration of standard-of-care treatment. The U.S. Food and Drug Administration granted APL-2 Fast Track Designation for the treatment of GA, which facilitates the development and expedites the review of investigational therapies to treat serious conditions and fill an unmet medical need. Apellis is currently enrolling two global confirmatory Phase 3 studies for patients with GA. These identical, prospective, multicenter, randomized, double-masked, sham-injection controlled studies are designed to assess the efficacy and safety of multiple IVT injections of APL-2 in patients with GA secondary to AMD.

08:08 EDT Beazer Homes reports first two months of Q4 sales up 12.5% - Beazer Homes announced that its sales for the first two months of its fiscal fourth quarter were up 12.5% year over year. This increase was primarily related to a higher pace, as sales per community per month rose to 3.0 from 2.7 in the previous year. In addition, the company continues to expect its fiscal fourth quarter backlog conversion ratio to be similar to the fourth quarter of the prior fiscal year. The company will report its full fourth quarter 2019 results in November and is not updating any additional guidance at this time.

08:07 EDT Artelo Biosciences announces reference of two CBD studies in Nature Medicine - Artelo Biosciences announced that two research studies conducted by the Company were featured in the September 2019 issue of Nature Medicine. Artelo sponsored research at the University of Nottingham, UK and the insights were published in two separate papers with a focus on how CBD behaves and affects the human body. Nature Medicine recognizes the importance Artelo's research findings and highlights the scarcity of data on CBD as well the limited availability of quality clinical research identifying the dose of CBD useful to treat certain diseases and conditions. "Nature Medicine identifies many of the challenges encountered in the development of a CBD based therapeutic. At Artelo we used a cocrystallization approach to develop our proprietary CBD cocrystal, ART12.11, which is anticipated to overcome many of the challenges highlighted in Nature Medicine," stated CEO Gregory Gorgas. "Cocrystallization is a proven strategy utilized by pharmaceutical companies to overcome limitations in absorption, stability and other pharmaceutical properties. It also offers the opportunity to establish a strong patent position which is essential for product commercialization."

08:06 EDT Sabre announces collaboration with Singapore Airlines - Sabre announced a collaboration with Singapore Airlines for the expansion of their NDC program, the KrisConnect Programme. Effective November 2019, this venture will provide select Sabre connected agents in Singapore with the ability to access and book unique NDC content from Singapore Airlines. As the program continues to roll-out across the region, all Sabre connected agents will have the ability to leverage KrisConnect.

08:05 EDT scPharmaceuticals plans to resubmit FUROSCIX NDA by mid-year 2020 - scPharmaceuticals provided an update on FUROSCIX and announced a new $20M term loan with Solar Capital Ltd. and Silicon Valley Bank. FUROSCIX is scPharmaceuticals' lead program for the treatment of congestion in patients with heart failure. The Company continues to execute on key milestones ahead of resubmission of the NDA, including drug stability testing, the advancement of its second human factors study, and increasing awareness of FUROSCIX within the medical community. The Company is reiterating prior guidance and remains confident it will resubmit the FUROSCIX NDA with the U.S. Food and Drug Administration by mid-year 2020. Drug stability testing is a required element of the FUROSCIX resubmission and a requirement of all drug products undergoing regulatory review. The Company has recently completed the requisite three primary batches of drug product. These batches will form the basis of the drug stability portion of the FUROSCIX resubmission. Two human factors studies designed to assess and optimize user interaction with the FUROSCIX Infusor interface are to be conducted under the current 505(b)(2) approval pathway for FUROSCIX. The Company announced the completion of the first study in August 2019. The Company has submitted and received feedback from the FDA on the human factors validation study and is on track to complete the second study by the end of the year. The second study will evaluate the usability of FUROSCIX by patients, caregivers, and healthcare providers. A poster on the use of FUROSCIX in patients after hospitalization for acute decompensated heart failure was presented at the HFSA on September 14th, 2019, in Philadelphia, PA. The Company announced a restructured four-year term loan facility that allows for an expansion of the Company's prior $10M credit facility to $20M, all of which has been drawn at closing. The proceeds from the loan will be used to pay off the existing $10M term loan along with related fees and expenses, and to provide additional working capital for general corporate purposes. The restated and amended agreement extends the term of the credit facility until September 17, 2023 and permits the Company to make interest-only payments until October 1, 2021.

08:03 EDT Commercial Vehicle Group acquires First Source Electronics for $44.75M - Commercial Vehicle Group announced the acquisition of substantially all of the assets and assumption of certain liabilities of First Source Electronics, a leading electronics systems integrator based in Elkridge, MD that serves a diverse range of market segments including industrials, transportation and military. FSE's trailing twelve month sales as of June 30 was approximately $46M. The transaction is expected to be accretive to operating income and earnings per share in year one. Total cash consideration for the transaction of as much as $44.75M, with $34M due at closing and the balance due in twelve, eighteen, and thirty-six months, subject to meeting certain targets. The transaction was funded with domestic cash on hand and $2M availability under a revolving credit facility.

07:45 EDT Auxly Cannabis announces Canadian brokerage agreement with Kindred Partners - Auxly Cannabis Group and Kindred Partners announce that they have entered into a brokerage agreement pursuant to which Kindred will act as Auxly's exclusive sales agent for its adult-use cannabis products in Canada. Kindred is a Toronto-based specialty cannabis brokerage serving the adult-use market. Kindred will provide its brokerage services to Auxly and use its national presence to market the company's portfolio of brands nationwide.

07:40 EDT vTv Therapeutics presents additional data from Phase 2 Simplici-T1 study - vTv Therapeutics presented additional positive data from its phase 2 Simplici-T1 study in patients with type 1 diabetes at the 55th Annual Meeting of the European Association for the Study of Diabetes. In a poster titled "Results from the sentinel and learning phase of the Simplici-T1 study, the first clinical trial to test activation of glucokinase as an adjunctive treatment for type 1 diabetes", Dr. Carmen Valcarce, Chief Scientific Officer at vTv Therapeutics presented new continuous glucose monitor and insulin dose data from the patients with complete CGM profiles in the completed Phase 2 - Part 1 of the study. Key results presented included: TTP399 treatment increased Time in Range from baseline to end of treatment by 11% per day, and by 12% during the critical waking hours relative to placebo. TTP399 treatment reduced the total daily mealtime bolus insulin dose by 23% compared to 4% for placebo while significantly improving glycemic control. Patients in the treatment group experienced fewer Level 1 and Level 2 hypoglycemic events than patients in the placebo group.

07:36 EDT Accelerate Diagnostics reports 'positive' results in three Pheno system studies - Accelerate Diagnostics released "positive" results from three clinical studies on the Accelerate Pheno system that will be presented at IDWeek 2019. The first of these studies is the ARLG-sponsored RAPIDS-GN clinical study conducted at Mayo Clinic and UCLA. The study successfully achieved its primary endpoint, demonstrating a statistically significant reduction in time to first antibiotic change for patients with Gram-negative blood stream. RAPIDS-GN is the first multi-center, randomized controlled trial to evaluate the impact of rapid ID and AST technology for the management of patients with blood stream infections. As expected, differences in secondary endpoints like mortality and length of stay did not achieve statistical significance. Two abstracts to confirm and extend the findings of RAPIDS-GN. The University of Iowa showed antibiotic therapy was optimized within 15.3 hours for patients tested with Pheno. Among 277 interventions made based on Pheno results, 80% resulted in antibiotic change, and over one third were due to the patient not being covered for the causative organism identified. Similarly, UAMS found a 1.1 day improvement in time to optimal therapy and confirmed prior findings that demonstrated between 0.5 and 2.4 days shorter length of stay for patients with bacteremia and tested by Pheno over historical cohorts.

07:32 EDT Equifax partners with Urjanet for utility payment data sharing platform - Equifax and Urjanet announced a global partnership that empowers consumers and businesses to share their payment data from thousands of utility, telecom and cable providers worldwide for a more complete picture of individual payment history, easier identity verification and the potential for better access to credit. This partnership uses the Urjanet Utility Data Platform to incorporate consumer-permissioned data into the Equifax differentiated data approach. Urjanet enables consumer-permissioned access to information from more than 6,500 electricity, natural gas, water, waste, cable and telecom providers in 47 countries around the world.

07:32 EDT Biogen to initiate DEVOTE clinical trial evaluating higher dose of SPINRAZA - Biogen announced updates to the SPINRAZA clinical development program including the initiation of a new global clinical trial, DEVOTE. The DEVOTE study will evaluate if a higher dose of SPINRAZA can provide even greater efficacy in the treatment of spinal muscular atrophy across a broad patient population. In addition, new data further demonstrating the safety and efficacy of treatment with SPINRAZA in individuals with later-onset SMA will be featured in a podium presentation at the 13th Congress of the European Paediatric Neurology Society. Building on the demonstrated long-term safety profile and proven efficacy of SPINRAZA in a broad range of patients, the DEVOTE trial will examine the potential for even greater efficacy, as well as the safety and tolerability of SPINRAZA, when administered at a higher dose. The trial is a Phase 2/3 randomized, controlled dose-escalating study that will be conducted at 50 sites around the world with a projected enrollment of 126 individuals with SMA of all ages, including adults. The three-part trial will include an open-label safety evaluation and a pivotal, double-blind, active control randomized treatment period followed by an open-label treatment period. After the safety evaluation, the trial will compare two loading doses of 50 milligrams 15 days apart followed by a maintenance dose of 28 mg every four months with the current U.S. Food and Drug Administration-approved administration of SPINRAZA, which is four loading doses with 12 mg maintenance doses every four months. The third part of the trial will be an open-label evaluation to determine how to safely and efficiently transition patients from the currently approved dose of SPINRAZA to the higher dose being tested in the study.

07:12 EDT BeyondSpring sees sufficient cash to submit NDAs in China for Plinabulin - As of June 30, 2019, the Company has a cash balance of $0.7M. With the net proceeds received from the recent equity, the Company believes it has sufficient cash to support its clinical trials and submit NDAs in China for Plinabulin for the treatment of CIN and NSCLC, and to advance its immuno-oncology pipeline and its ubiquitination protein degradation research platform.

07:07 EDT Plug Power announces hydrogen supply agreement with United Hydrogen - Plug Power and United Hydrogen announced a new hydrogen supply agreement. The alliance was formalized earlier this month with the signing of a three-year reserved product supply agreement between the two companies and will allow Plug Power to maintain competitive pricing for its current customer base, while also provisioning for future growth. Under the agreement, United Hydrogen will supplement Plug Power's hydrogen delivery operation with a dedicated supply of liquid hydrogen.

07:06 EDT BNY Mellon announces strategic alliance with Bloomberg - The Bank of New York Mellon and Bloomberg announced a strategic alliance that further integrates BNY Mellon's data, analytics, and servicing capabilities with AIM, Bloomberg's portfolio management, trading and compliance solution. The new connectivity streamlines data delivery between the two firms and enables clients to access BNY Mellon's data and analytical workflow tools directly through Bloomberg AIM, delivering unique capabilities and insights to investors, technology leaders, and risk and operations professionals.

07:04 EDT Plug Power announces five-year plan targeting $1B of revenue by 2024 - Plug Power has rolled out a new five-year plan to position the company to deliver on an annual basis by 2024 $1B of revenue, $170M of operating income, and $200M of adjusted EBITDA. The plan is being presented during the 2019 Plug Power Symposium in Latham, NY. The majority of the revenue growth is expected to come from material handling industry, the Company's core market, with increasing contribution from on-road and stationary markets. Operating margin and adjusted EBITDA margin expansion reflects underlying operating leverage in the business model with potential for upside from the multiple potential strategic moves in the hydrogen generation business. Within its core market of material handling, the Company expects to generate annual revenue of approximately $750M and sell more than 25,000 units annually by 2024, up from about $235M to $245M of expected revenue in 2019, an increase of over 3X. Plug Power expects that this revenue acceleration will come from continued growth from its anchor customers and the addition of one new multi-site customer on an annual basis, coupled with expansion in Europe/additional channel partners. By 2024 the Company expects to generate $200M of annual revenue from the on-road electric vehicle market and $50M of revenue from stationary applications. The Company estimates that the global total available market for the material handling industry currently is about $30B. With its entry into the on-road market, the Company believes the medium-term addressable market opportunity increases more than 3X to over $100B and the long-term addressable market opportunity increases 10X to $300B. PLUG Power will also highlight its position in the hydrogen business as the Company has now become the largest buyer of liquid hydrogen in the world with over 80 hydrogen stations deployed. The Company internal demand for hydrogen is expected to increase to 85tons per day by 2024, up from 20tons per day today. The Company is exploring various strategic initiatives, which could turn hydrogen into a substantial recurring cash generating business and providing upside to current operating income and adjusted EBITDA targets for 2024. Plug Power will also discuss its technology position in the industry. Plug Power is the largest MEA manufacturer in the US and plans to be the largest MEA manufacturer in the world by 2024. The Company will also provide details on its path to get to operating income margin to 17% and adjusted EBITDA margin to 20%.

07:04 EDT Oceaneering awarded contracts to supply subsea umbilicals by Baker Hughes - Oceaneering (OII) has been awarded contracts by Baker Hughes (BHGE), a partner in the consortium for the Oil & Natural Gas Corporation of India KG-DWN 98/2 deepwater field development in the Bay of Bengal, to supply subsea umbilical control systems. Oceaneering's scope comprises the subsea umbilical control systems to allow production of gas from fields U and R, and oil from fields A, P, and M. Manufacture of the umbilicals is scheduled to occur at Oceaneering's facility in Rosyth, Scotland and is expected to commence in 3Q19 and be completed in 1Q21.

06:53 EDT Sierra Metals increases issuer current normal issuer bid to 2.5M share target - Sierra Metals announced that the Toronto Stock Exchange has accepted its intention to amend its previously announced Normal Course Issuer Bid to increase the number of common shares of the company which the company may repurchase for cancellation under the NCIB from 1. 5M shares, or approximately 0.92% of the issued and outstanding Shares, to 2.5M shares, representing approximately 1.54% of the company's issued and outstanding Shares as of September 17. Under the NCIB, which commenced on December 17, 2018, the company has repurchased and cancelled a total of 1,457,822 Shares at a weighted average price of $1.9307 per Share. The NCIB is still set to terminate on December 16.

06:34 EDT Southwest sees Q3 capacity down approxiamtely 3% vs. previous down 2%-3% view - The company now expects its third quarter 2019 year-over-year ASMs, or capacity, to decrease approximately 3%, as compared with its previous guidance of a year-over-year decrease in the range of 2%-3%. The company canceled a total of approximately 600 flights in September 2019 due to Hurricane Dorian, which the company expects will have an immaterial impact on its third quarter 2019 financial results.

06:33 EDT Southwest continues to see Q3 fuel costs $2.05-$2.15 per gallon - Based on the company's fuel derivatives contracts and market prices as of September 16, 2019, the company continues to expect its third quarter 2019 fuel costs to be in the range of $2.05 to $2.15 per gallon, including $.04 per gallon in premium expense, with no cash settlements from fuel derivative contracts. The company continues to expect its third quarter 2019 available seat miles per gallon, or fuel efficiency, to decrease in the range of 1 to 2 percent, year-over-year, primarily due to the removal of the company's most fuel-efficient aircraft from its schedule as a result of the MAX groundings.

06:32 EDT Air Lease announces delivery of one new Boeing 787-9 aircraft to Neos - Air Lease (AL) announced the delivery of one new Boeing (BA) 787-9 aircraft on long-term lease to Neos. Featuring Rolls-Royce Trent 1000 engines, this aircraft delivered from ALC's order book with Boeing.

06:14 EDT Airbus forecasts need for over 39,000 new aircraft in next 20 years - The world's passenger and freighter aircraft fleet is set to more than double from today's nearly 23,000 to almost 48,000 by 2038 with traffic growing at 4.3% annually, also resulting in a need for 550,000 new pilots and 640,000 new technicians, Airbus said in a statement. By 2038, of the forecast 47,680 fleet, 39,210 are new and 8,470 remain from today. By updating fleets with latest generation fuel efficient aircraft such as the A220, A320neo Family, the A330neo and the A350, Airbus believes it will largely contribute to the progressive decarbonisation of the air transport industry and the objective of carbon neutral growth from 2020 while connecting more people globally. "The 4% annual growth reflects the resilient nature of aviation, weathering short term economic shocks and geo-political disturbances. Economies thrive on air transportation. People and goods want to connect," said Christian Scherer, Airbus Chief Commercial Officer and Head of Airbus International. "Globally, commercial aviation stimulates GDP growth and supports 65 million livelyhoods, demonstrating the immense benefits our business brings to all societies and global trade."

06:04 EDT Bright Scholar announces $30M share repurchase program, declares dividend - Bright Scholar Education announced that its board has approved a $30M share repurchase program, and has approved and declared a cash dividend of 10c per ordinary share. The dividends are expected to be paid on October 11, to the holders of the company's ordinary shares of record as of the close of business on September 30.

05:32 EDT Bloom Energy says Hindenburg Research report had 'factual inaccuracies' - Bloom Energy issued the following statement. "A report about Bloom Energy published by a known short seller, Hindenburg Research, presented factual inaccuracies, misleading allegations, and drew erroneous conclusions, including about the future viability of Bloom. We feel obligated to correct the record with respect to certain allegations in the report for our investors, customers, partners and employees... Of the $701 million of debt reflected on Bloom's June 30, 2019 balance sheet, $269.5 million is PPA debt that is non-recourse to Bloom. For calendar years 2016 - 2018, Bloom fuel cells have an average life of 4.8 to 5.2 years At these expected fuel cell lives, Bloom estimates future service revenue will exceed future service cost, resulting in longer-term service profit. Distinct from service revenue, Bloom receives product revenue for upgrades to Energy Servers Bloom Energy produces significantly lower emissions than the grid in all states in which it operates Bloom Energy is an innovative and growing company that delivers important power resiliency and sustainability benefits to customers. Our mission is to make clean, reliable, and affordable energy for everyone in the world. The company's product, the Bloom Energy Server, delivers highly reliable and resilient, 'Always-On' electric power that is clean and sustainable. To date, our 600 Energy Server deployments worldwide have helped customers cumulatively reduce their carbon dioxide emissions by more than 4.5 billion pounds, and have avoided more than 164 billion gallons of water withdrawal compared to electricity generated from the grid. Bloom Energy also has a proven track record of providing power resiliency and reliability for our customer facilities through our microgrid solutions. These solutions are becoming increasingly important at a time when grid outages are escalating due to aging infrastructure and a higher frequency of natural disasters. We have deployed 85 microgrids globally and powered customer facilities through more than 550 outages in 2018... The erroneous and misleading statements in the report include Bloom's ability to satisfy our convertible debt obligation, our future service costs and the impact of upgrading certain customer sites. Bloom's debt on the balance sheet, as of June 30th 2019, contains debt that is both recourse to Bloom and non-recourse. As of June 30, 2019, $269.5 million of PPA project company debt is reflected on the balance sheet and is non-recourse to Bloom. The balance sheet debt as of June 30, 2019 does include $432 million of recourse debt, of which $296.2 million represents convertible notes due in December 2020. On or before December 2020, in the event this convertible debt is not converted to equity, Bloom may do one or more of the following: refinancing existing debt, issue new debt or issue equity."

05:24 EDT Ironwood, AstraZeneca amend LINZESS collaboration in China - Ironwood Pharmaceuticals (IRWD) announced that it has amended its collaboration agreement with AstraZeneca (AZN) for the development and commercialization of LINZESS in China. LINZESS was approved by the National Medical Products Administration for adults with IBS-C in China in January 2019. LINZESS is expected to be launched in China in the second half of 2019. Under the terms of the amended agreement, AstraZeneca will obtain exclusive rights to develop, manufacture and commercialize linaclotide in China, including Hong Kong and Macau, and will be responsible for all expenses associated with these activities. In return, Ironwood will receive up to a total of $125 million, including non-contingent payments totaling $35M paid in three installments through 2024 and up to $90M in commercial milestone payments contingent on the achievement of certain net sales targets. Additionally, Ironwood will receive royalties beginning in the mid-single-digit percent and increasing up to 20% based on annual net sales of LINZESS in China. In connection with the amended agreement, Ironwood will no longer be jointly funding the development and commercialization of linaclotide or sharing in the net profit from sales in China.

05:20 EDT Capital One, Walmart introduce Capital One Walmart Rewards Credit Card Program - Capital One and Walmart are introducing the Capital One Walmart Rewards Credit Card Program, which launches with two new credit cards that reward customers for shopping at Walmart and on purchases they make everywhere the card is accepted. The program's signature co-branded card, the Capital One Walmart Rewards Mastercard, and the private-label card exclusively for Walmart purchases, the Walmart Rewards Card, will be available beginning September 24.